Neogen Q3 Earnings Fall Short On Expectations, Cuts Guidance Amid Macro Headwinds And Tariff Concerns

Neogen Corp. (NASDAQ:NEOG) reported third-quarter 2025 adjusted EPS of 10 cents on Wednesday, down from 12 cents a year ago, missing the consensus of 11 cents.

The company reported sales of $220.98 million, down 3.4% year over year, missing the consensus of $224.88 million.

Core revenue, which excludes the impacts of foreign currency translation and acquisitions completed and product lines discontinued in the last 12 months, increased by 0.2%.

Acquisitions and discontinued product lines had a negative impact of 0.5% while foreign currency had a negative impact of 3.1%.

The gross margin was 49.9% down from 51.1% a year ago, mainly due to lower revenue and higher integration costs. Excluding integration and restructuring costs, gross margin was 51.5% in the third quarter compared to 51.8% in the prior-year quarter.

Also Read: Cartesian Therapeutics Reports Strong 12-Month Data ...

https://www.benzinga.com/general/health-care/25/04/44709995/neogen-q3-earnings-fall-short-on-expectations-cuts-guidance-amid-macro-headwinds-and-tariff-c